Patent Litigation Financing

Financial Options for Patent Owners and Litigators

"There has probably never been a more spectacular public vindication of the benefits of litigation finance than Samsung's payment of $150 million to settle a case... In a lawsuit funded by GLS Capital."
Patent litigation finance works: no wonder some want it curtailed.
IAM. Feb. 9, 2023

IP & Patent Litigation

Our Process

GLS Capital provides our counterparties with the capital and expertise needed to acquire, manage and monetize IP and patent portfolios.

In the past two years our counterparties have achieved more than a billion dollars in verdicts, judgments and settlements in matters that GLS has funded.

Our patent litigation team assists counterparties and their law firms with the expense of litigating and monetizing their IP assets. Our expertise in patent litigation and monetization is often recognized and appreciated as an additional asset by our counterparties and their counsel.

We are proud of our assistance in helping counterparties to obtain recognition and compensation for their inventions and contributions in their technical fields.

Leaders in IP & Patent Litigation Finance

The GLS Capital team are leaders in the industry for designing customized patent litigation finance solutions for businesses, patent holders, and law firms.

GLS provides counterparties capital to finance a portion of legal counsel fees and/or out of pocket costs for litigation.

GLS provides capital for the purchase of IP to monetized, for program costs for IP enforcement and for cases or broad campaigns regarding patent portfolios.

GLS invests in trademark, copyright, trade secret litigation and other non-patent IP disputes. While potentially not as technically complex as patent litigation, these claims often require specific legal experience and significant capital due to their complex statutory regimes.

IP litigation in pharmaceutical and life sciences require an additional layer of technical expertise and often industry knowledge. GLS has substantial, in-house pharmaceutical and commercialization expertise that allows us to both underwrite and add strategic value to these disputes.

Click to learn more about how we supported Nanoco in obtaining recognition and compensation for their fundamental inventions.

Learn More

Our Team

Our patent investment team is led by former litigation partners at elite law firms and is ranked Band 1 by Chambers & Partners* reflecting our experience and leadership in patent litigation financing.

Meet The Team

Adam Gill

See Bio

Joel Merkin

See Bio

Hannah Sadler

See Bio

*The ranking by Chambers & Partners was as of June 2026 based on information collected earlier in 2026. No compensation has been provided directly or indirectly by GLS Capital in connection with its ranking in Chambers Litigation Support. However, GLS Capital does maintain an account with Chambers & Partners containing a firm profile which requires the payment of an annual fee.

Skip to content